392 related articles for article (PubMed ID: 25937240)
21. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
[TBL] [Abstract][Full Text] [Related]
22. Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers.
Weerts EM; Wand GS; Maher B; Xu X; Stephens MA; Yang X; McCaul ME
Alcohol Clin Exp Res; 2017 Jun; 41(6):1093-1104. PubMed ID: 28376280
[TBL] [Abstract][Full Text] [Related]
23. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
[TBL] [Abstract][Full Text] [Related]
24. OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence.
Gegenhuber B; Weinland C; Kornhuber J; Mühle C; Lenz B
Eur Neuropsychopharmacol; 2018 Dec; 28(12):1418-1428. PubMed ID: 30322771
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin modulates mesolimbic reactivity to alcohol cues in alcohol-addicted subjects: a functional imaging study.
Koopmann A; Bach P; Schuster R; Bumb JM; Vollstädt-Klein S; Reinhard I; Rietschel M; Witt SH; Wiedemann K; Kiefer F
Addict Biol; 2019 Sep; 24(5):1066-1076. PubMed ID: 29984874
[TBL] [Abstract][Full Text] [Related]
26. Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: an event-related functional magnetic resonance imaging study.
Li Q; Li W; Wang H; Wang Y; Zhang Y; Zhu J; Zheng Y; Zhang D; Wang L; Li Y; Yan X; Chang H; Fan M; Li Z; Tian J; Gold MS; Wang W; Liu Y
Addict Biol; 2015 Sep; 20(5):968-78. PubMed ID: 25214465
[TBL] [Abstract][Full Text] [Related]
27. Subjective responses to alcohol in the lab predict neural responses to alcohol cues.
Courtney KE; Ray LA
J Stud Alcohol Drugs; 2014 Jan; 75(1):124-35. PubMed ID: 24411804
[TBL] [Abstract][Full Text] [Related]
28. Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial.
Vollstädt-Klein S; Loeber S; Kirsch M; Bach P; Richter A; Bühler M; von der Goltz C; Hermann D; Mann K; Kiefer F
Biol Psychiatry; 2011 Jun; 69(11):1060-6. PubMed ID: 21292243
[TBL] [Abstract][Full Text] [Related]
29. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
[TBL] [Abstract][Full Text] [Related]
30. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
31. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.
Bart G; Kreek MJ; Ott J; LaForge KS; Proudnikov D; Pollak L; Heilig M
Neuropsychopharmacology; 2005 Feb; 30(2):417-22. PubMed ID: 15525999
[TBL] [Abstract][Full Text] [Related]
32. OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients.
Foulds JA; Ton K; Kennedy MA; Adamson SJ; Mulder RT; Sellman JD
Pharmacogenet Genomics; 2015 May; 25(5):270-3. PubMed ID: 25715171
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism in the µ-opioid receptor gene (OPRM1) modulates neural processing of physical pain, social rejection and error processing.
Bonenberger M; Plener PL; Groschwitz RC; Grön G; Abler B
Exp Brain Res; 2015 Sep; 233(9):2517-26. PubMed ID: 26019010
[TBL] [Abstract][Full Text] [Related]
34. A comparison of region-of-interest measures for extracting whole brain data using survival analysis in alcoholism as an example.
Reinhard I; Leménager T; Fauth-Bühler M; Hermann D; Hoffmann S; Heinz A; Kiefer F; Smolka MN; Wellek S; Mann K; Vollstädt-Klein S
J Neurosci Methods; 2015 Mar; 242():58-64. PubMed ID: 25593047
[TBL] [Abstract][Full Text] [Related]
35. Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.
Setiawan E; Pihl RO; Benkelfat C; Leyton M
Pharmacogenomics; 2012 Jul; 13(10):1161-72. PubMed ID: 22909206
[TBL] [Abstract][Full Text] [Related]
36. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol.
Ray LA; Bujarski S; Squeglia LM; Ashenhurst JR; Anton RF
Alcohol Alcohol; 2014; 49(3):261-70. PubMed ID: 24421289
[TBL] [Abstract][Full Text] [Related]
37. Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients.
Beck A; Wüstenberg T; Genauck A; Wrase J; Schlagenhauf F; Smolka MN; Mann K; Heinz A
Arch Gen Psychiatry; 2012 Aug; 69(8):842-52. PubMed ID: 22868938
[TBL] [Abstract][Full Text] [Related]
38. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity.
Ray LA; Bujarski S; MacKillop J; Courtney KE; Monti PM; Miotto K
Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1(Suppl 1):E116-24. PubMed ID: 23240711
[TBL] [Abstract][Full Text] [Related]
39. Cortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.
Lovallo WR; Enoch MA; Acheson A; Cohoon AJ; Sorocco KH; Hodgkinson CA; Vincent AS; Glahn DC; Goldman D
Neuropsychopharmacology; 2015 Oct; 40(11):2546-54. PubMed ID: 25881118
[TBL] [Abstract][Full Text] [Related]
40. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
